Comprehensive Treatment in Depressed or Anxious Patients Suffering Diabetes Mellitus Type 2

Abstract

Objective: describe the response of patients, diagnosed with diabetes mellitus type 2 (dm2), depression or anxiety, to a comprehensive treatment. Methods: quasi-experimental study, sample of 39 patients, beneficiaries of a Family Medicine Clinic in Mexico City, assessed from February to June 2017. Patients with uncontrolled dm2, and depression or anxiety diagnosis were included. The scales of Zung and Beck were used to assess depression and anxiety, respectively. A comprehensive management was given, including pharmacological adjustment, psycho-educational and nutritional interventions. A post-treatment evaluation was carried out and new clinical and biochemical parameters were collected. The Wilcoxon range test was used to relate the glycosylated hemoglobin values and to compare the results of the depression and anxiety depression before and after the treatment. Results: an average age of 52 +- 8.12 years, with 59% (n=23) female. The media in the pre-intervention was: 10.29 +-2.29% for HbA1c, 53.1 +-8.47 points for depression and 14.82 +-8.08 points for anxiety. The post-intervention results were: 7.53 +-1.56% for HbA1c, 45.12 +-8.83 points for depression and 9.38 +-7.28 points for anxiety, with statistically significant differences p<0.05 for HbA1c, depression, and anxiety. Conclusions: comprehensive treatment in patients with Diabetes Mellitus Type 2 reduces the HbA1C levels and the symptomatology level of depression or anxiety; other studies are required to evaluate the treatment effectiveness.